GH1 and diabetes mellitus: Estrogen modulates growth hormone secretory activity in a biphasic manner; low levels of estrogen stimulate secretion of IGF-1 through growth hormone release, whereas high levels inhibit IGF-1 production resulting in menarche (29,30), indicating that early exposure to higher levels of estrogens may lead to diabetes in the future (31).